IT1228537B - Derivati della cisteina ad azione espettorante - Google Patents

Derivati della cisteina ad azione espettorante

Info

Publication number
IT1228537B
IT1228537B IT8721514A IT2151487A IT1228537B IT 1228537 B IT1228537 B IT 1228537B IT 8721514 A IT8721514 A IT 8721514A IT 2151487 A IT2151487 A IT 2151487A IT 1228537 B IT1228537 B IT 1228537B
Authority
IT
Italy
Prior art keywords
derivatives
acid
cistein
chem
salts
Prior art date
Application number
IT8721514A
Other languages
English (en)
Other versions
IT8721514A0 (it
Inventor
Laura Puricelli
Original Assignee
Magis Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis Farmaceutici filed Critical Magis Farmaceutici
Priority to IT8721514A priority Critical patent/IT1228537B/it
Publication of IT8721514A0 publication Critical patent/IT8721514A0/it
Priority to DE88112028T priority patent/DE3884508T2/de
Priority to EP88112028A priority patent/EP0301474B1/en
Priority to ES88112028T priority patent/ES2059450T3/es
Priority to AT88112028T priority patent/ATE95171T1/de
Priority to US07/225,769 priority patent/US4910222A/en
Application granted granted Critical
Publication of IT1228537B publication Critical patent/IT1228537B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IT8721514A 1987-07-30 1987-07-30 Derivati della cisteina ad azione espettorante IT1228537B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT8721514A IT1228537B (it) 1987-07-30 1987-07-30 Derivati della cisteina ad azione espettorante
DE88112028T DE3884508T2 (de) 1987-07-30 1988-07-26 Cystein-Derivate mit Expectorans-Wirkung.
EP88112028A EP0301474B1 (en) 1987-07-30 1988-07-26 New cysteine derivatives having expectorant activity
ES88112028T ES2059450T3 (es) 1987-07-30 1988-07-26 Nuevos derivados de cisteina que tienen actividad expectorante.
AT88112028T ATE95171T1 (de) 1987-07-30 1988-07-26 Cystein-derivate mit expectorans-wirkung.
US07/225,769 US4910222A (en) 1987-07-30 1988-07-29 Cysteine derivatives having expectorant activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8721514A IT1228537B (it) 1987-07-30 1987-07-30 Derivati della cisteina ad azione espettorante

Publications (2)

Publication Number Publication Date
IT8721514A0 IT8721514A0 (it) 1987-07-30
IT1228537B true IT1228537B (it) 1991-06-20

Family

ID=11182939

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8721514A IT1228537B (it) 1987-07-30 1987-07-30 Derivati della cisteina ad azione espettorante

Country Status (6)

Country Link
US (1) US4910222A (it)
EP (1) EP0301474B1 (it)
AT (1) ATE95171T1 (it)
DE (1) DE3884508T2 (it)
ES (1) ES2059450T3 (it)
IT (1) IT1228537B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184344B1 (en) 1995-05-04 2001-02-06 The Scripps Research Institute Synthesis of proteins by native chemical ligation
ES2161885T3 (es) * 1995-05-04 2001-12-16 Scripps Research Inst Sintesis de proteinas mediante ligacion quimica natural.
AU2002220121A1 (en) * 2000-11-28 2002-06-11 Lorillard Licensing Company, Llc A smoking article including a selective carbon monoxide pump
US6481442B1 (en) 2000-11-28 2002-11-19 Lorillard Licensing Company, Llc Smoking article including a filter for selectively removing carbonyls
EP2408443A1 (en) 2009-03-16 2012-01-25 Genmedica Therapeutics SL Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
WO2013037984A1 (en) 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2406362A (en) * 1943-11-11 1946-08-27 Du Pont Process
FR4619M (it) * 1965-02-01 1966-11-28

Also Published As

Publication number Publication date
EP0301474B1 (en) 1993-09-29
US4910222A (en) 1990-03-20
ATE95171T1 (de) 1993-10-15
DE3884508D1 (de) 1993-11-04
ES2059450T3 (es) 1994-11-16
IT8721514A0 (it) 1987-07-30
EP0301474A2 (en) 1989-02-01
DE3884508T2 (de) 1994-02-03
EP0301474A3 (en) 1989-10-04

Similar Documents

Publication Publication Date Title
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
PT89111A (pt) Processo de preparacao de analogos de camptotecina hidrossoluveis, dos seus intermediarios e de composicoes que os contem
OA09039A (fr) Acides 3-alcenyl-1-azabicyclo(3.2.0)hep-2-ene-2carboxyliques
ATE45580T1 (de) 9-(2-hydroxyethoxymethyl)guanin-derivate.
PT92935A (pt) Processo para a preparacao de um composto de pirazolo-piridina e de composicoes farmaceuticas que o contem
ES8103743A1 (es) Un metodo para la preparacion de derivados de ftalimidina
ES2057016T3 (es) Compuestos de acido 3-pirrolidiniltio-1-azabiciclo (3.2.0) hept-2-eno-2-carboxilico.
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
IT1137640B (it) Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
DK390587D0 (da) 7-oeoe3-aminomethyl-3-alkylaa-1-pyrrolidinylaa-quino lin-carboxylsyre
UA42696C2 (uk) Складні ефіри сірчаної кислоти цукрових спиртів для лікування та/або профілактики артеріосклеротичних змін стінок судин і лікарський засіб, що їх містить
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
DK166323C (da) Griseolsyrederivater og farmaceutiske midler indeholdende disse
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
IT1228537B (it) Derivati della cisteina ad azione espettorante
FR2450820A1 (fr) Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation
FI861655A0 (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
PT78970A (fr) Procede de preparation de derives de triazolo-pyrimidine ayant activite toni-cardiaque et de compositions pharmaceutiques les contenant
ES8801173A1 (es) Procedimiento de producir agentes terapeuticos y profilacticos para ulceras pepticas
PT82815B (pt) Processo de preparacao de derivados da imidazolidina, dos seus sais farmaceuticamente aceitaveis e das composicoes farmaceuticas que os contem
DE3371627D1 (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
ES465537A1 (es) Un procedimiento para la preparacion de un alcohol-x-(3,4- dimetoxifenetilaminometil)-2-alcoxibencilico racemico u op- ticamente activo
SE8501518L (sv) Farmaceutiska preparat
ES8306087A1 (es) Un procedimiento para la preparacion de una cetona biciclica.
HUT54039A (en) Process for producing galenic compositions ensuring optimal biological accessibility of 2-hydroxy-5-methyllaurophenoneoxime active ingredient